Table 4.
Japan symptom and impact concept frequency and disturbance ratings: number of patients who mentioned a concept and disturbance ratings of those concepts
| Core conceptsa | Number (% of N) of patients mentioning concept (N = 18) (%) | Disturbance ratingb |
|---|---|---|
| Symptom concepts | ||
| Nausea | 17 (94.4) | 4 |
| Fatigue | 16 (88.9) | 8 |
| Headache | 16 (88.9) | 7 |
| Shortness of breath | 15 (83.3) | 9 |
| Weakness | 15 (83.3) | 8 |
| Vomiting | 14 (77.8) | 4 |
| Bleeding | 13 (72.2) | 6 |
| Cardiovascular problems | 12 (66.7) | 7 |
| Dizziness | 12 (66.7) | 5 |
| Fever | 12 (66.7) | 5 |
| Poor healing | 12 (66.7) | 4 |
| Anemia | 11 (61.1) | 5 |
| Diarrhea | 11 (61.1) | 3 |
| Constipation | 9 (50.0) | 2 |
| Infection | 9 (50.0) | 8 |
| Pain | 9 (50.0) | 8 |
| Impact concepts | ||
| Anxiety | 17 (94.4) | 5 |
| Decreased ability to function | 17 (94.4) | 6 |
| Remission uncertainty | 17 (94.4) | 10 |
| Financial difficulties | 14 (77.8) | 5 |
| Appetite loss | 13 (72.2) | 4 |
| Decreased ability to maintain social/familial role | 13 (72.2) | 8 |
| Fear | 12 (66.7) | 5 |
| Problems concentrating | 11 (61.1) | 5 |
| Risk of other cancer | 10 (55.6) | 10 |
| Weight loss | 10 (55.6) | 3 |
aCore concepts are defined as those reported by ≥50% of participants
bRatings based on a 0–10 scale (0 does not disturb, 10 greatly disturbing)